GANX 0.98 (-6.67%)
US36269B1052BiotechnologyBiotechnology

Gain Therapeutics (GANX) Stock Highlights

0.98 | -6.67%
2024-08-06 06:08:18
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders and oncology. The company has filed four patent applications for novel small molecule drug candidates that are Structurally Targeted Allosteric Regulators (STARs). The company derives revenues from collaboration and licensing agreements.

Statistics

Range Today
0.92 1
Volume Today 176K
Range 1 Year
0.94 5.33
Volume 1 Year 37.1M
Range 3 Year
0.94 9.75
Volume 3 Year 77.58M
Range 10 Year
0.94 17.93
Volume 10 Year 83.21M

Highlights

Market Capitalization 26.43M (micro)
Floating Shares 17.17M
Current Price 0.98
Price To Earnings -0.7
Price To Book 2.19
Earnings Per Share -1.5
Payout Ratio 0%

Performance

Latest -6.67%
1 Month -17.65%
3 Months -67.22%
6 Months -75.38%
1 Year -74.35%
3 Years -88.08%
5 Years -91.48%
10 Years -91.48%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.